Tri-Coast Pharmacy Recalls Vitamin D3 Due to Sterility Concerns
Tri-Coast Pharmacy is recalling 662 vials of compounded Vitamin D3 100,000 Unit/mL in olive oil because the agency cannot assure the products are sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving sterile products where sterility assurance is lacking.
Plain-English summary
Tri-Coast Pharmacy is voluntarily recalling 662 vials of Vitamin D3 100,000 Unit/mL in olive oil (30 mL). The recall is being conducted because the U.S. Food and Drug Administration (FDA) cannot assure the sterility of the products.
The recall includes all sterile products compounded between May 17, 2016, and November 17, 2016. The FDA has classified this recall as Class II, which means use of the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
The products were distributed nationwide. Consumers and healthcare providers should check their inventory for the specific lot codes listed in the recall notice and stop using the affected products. The FDA has not reported any illnesses or injuries associated with this recall.
The recalled product
- Product
- Vitamin D3 100,000 Unit/mL, in olive oil, (30 ML). Compounded by Tri-Coast Pharmacy
- Manufacturer
- Tri-Coast Pharmacy
- Affected units
- 662
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- 08152016C (02/11/2017)
- 10042016A (03/02/2017)
- 07282016D (01/24/2017)
- 09092016A (03/02/2016).
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 80 products in this recall →Related recalls
Same manufacturer · Tri-Coast Pharmacy
See all →- SevereTri-Coast Pharmacy Recalls Sermorelin Forte Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls BiMix Phentolamine/Papaverine Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Quad Mix Sterile Compounded Drug
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls MIC Ultra Cocktail Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereUS Compounding Recalls Vitamin D3 Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereFDA Recalls Vitamin D3 Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-06-03
- SevereWells Pharmacy Recalls Vitamin D3 Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- HighKey Pharmacy Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereFDA Recalls Vitamin D3 Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2019-04-24
- SeverePromise Pharmacy Recalls Vitamin D3 Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20